We therefore propose that the interactions between sphingomyelin (SM), enzymes of the Sphingomyelinase-Ceramide pathway, and Cer, modulate cytokine secretion and disease severity in COVID-19 patients (Fig. 6E). This evidence concerns the gene CBLN1 and COVID-19.